| Issue Type | Login |
|---|---|
| Country | Germany |
| Industry | Login |
| Region | Login |
| Maturity Date | 2030-05-15 |
| Par Value | 100000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 425.00 |
| Coupon | 7.5 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 425 |
| Min. Piece | Login |
| Min. Increment | Login |
This Cheplapharm Arzneimittel corporate bond has a 7.50% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 425.00 million EUR and matures on May 15, 2030 with a last coupon date of FEB 28, 2020. |
Cheplapharm Arzneimittel, founded in 1998 and headquartered in Greifswald, Germany, is a leading pharmaceutical company focused on the development and distribution of generic and specialty drugs. The company aims to improve access to essential medications across multiple therapeutic areas, including cardiology, gynecology, and endocrinology. Cheplapharm's robust portfolio comprises both established compounds and innovative therapies, catering to diverse patient needs while promoting sustainable healthcare solutions.